Incidence of venous thromboembolism and association with PD-L1 expression in advanced non-small cell lung cancer patients treated with first-line chemo-immunotherapy
BackgroundVenous thromboembolism (VTE) is a serious complication in non-small cell lung cancer (NSCLC) patients. The use of thromboprophylactic therapy is subject to an accurate assessment of the VTE risk depending on patients, tumor characteristics and type of systemic antineoplastic treatments. Ho...
Main Authors: | Liliana Aguiar De Azevedo, Charles Orione, Cécile Tromeur, Francis Couturaud, Renaud Descourt, Margaux Geier |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1221106/full |
Similar Items
-
Clinical epidemiology of venous thromboembolic disease: An institutional registry
by: Mohammed AlSheef, et al.
Published: (2022-07-01) -
Venous Thromboembolism in Hospitalized Melanoma Patients: Analysis from the National Inpatient Sample Database
by: Alhasson H, et al.
Published: (2021-11-01) -
Evolving Treatment Options for Cancer-Related Venous Thromboembolism∗
by: Doaa Attia, MD, et al.
Published: (2020-09-01) -
Descriptive Data of Patients with Venous Thromboembolism
by: Gul Ilhan
Published: (2013-08-01) -
Venous thromboembolism in viral diseases: A comprehensive literature review
by: Nasibeh Zerangian, et al.
Published: (2023-02-01)